FUSION PHARMACEUTICALS INC - COM (FUSN)

CUSIP: 36118A100

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM
Total 13F shares
27,229,348
Share change
-17,030
Total reported value
$319,948,353
Price per share
$11.75
Number of holders
36
Value change
-$261,229
Number of buys
17
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 36118A100?
CUSIP 36118A100 identifies FUSN - FUSION PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FUSION PHARMACEUTICALS INC - COM (FUSN) as of Q4 2020

As of 31 Dec 2020, FUSION PHARMACEUTICALS INC - COM (FUSN) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,229,348 shares. The largest 10 holders included Johnson & Johnson Innovation - JJDC, Inc., ADAMS STREET PARTNERS LLC, ORBIMED ADVISORS LLC, FMR LLC, CANADA PENSION PLAN INVESTMENT BOARD, TPG Group Holdings (SBS) Advisors, Inc., PERCEPTIVE ADVISORS LLC, Pivotal bioVenture Partners Investment Advisor LLC, Rock Springs Capital Management LP, and BlackRock Inc.. This page lists 36 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.